A Comparison of Diets with and without Oats in Adults with Celiac Disease
Esko K. Janatuinen, M.D., Pekka H. Pikkarainen, M.D., Tarja A. Kemppainen, M.Sc., Veli-Matti Kosma, M.D., Ritva M.K. Järvinen, M.Sc., Matti I.J. Uusitupa, M.D., and Risto J.K. Julkunen, M.D.
Background Wheat, rye, and barley damage the small-intestinalmucosa of patients with celiac disease; maize and rice are harmless.The effects of a diet containing oats are uncertain.
Methods In a randomized trial, we compared the effects of gluten-freediets without oats and with oats (with a goal of 50 to 70 gper day from three sources: two types of wheat-starch flourmixed with an equal amount of oats, muesli containing 60 percentoats, and rolled-oat breakfast cereal). Fifty-two adults withceliac disease in remission were followed for 6 months and 40with newly diagnosed disease for 12 months. Endoscopy with duodenalbiopsy was performed at the beginning and end of the study.
Results The mean (±SD) oat intake in the oat group was49.9±14.7 g per day at 6 months for patients in remissionand 46.6±13.3 g per day at 12 months for patients withnewly diagnosed disease. The oat and control groups did notdiffer significantly in nutritional status, symptoms, or laboratorymeasures. Patients in remission, regardless of diet, did nothave worsening architecture of the duodenal villi or increasedmononuclear-cell infiltration. All the patients with new diagnoseswere in remission at one year, except for one in the controlgroup. Six patients in the oat group and five in the controlgroup withdrew from the study.
Conclusions Moderate amounts of oats can be included in a gluten-freediet for most adult patients with celiac disease without adverseeffects.
Source Information
From the Division of Gastroenterology, Department of Medicine (E.K.J., R.J.K.J.), and the Department of Clinical Nutrition (M.I.J.U.), Kuopio University Hospital, Kuopio; the Division of Gastroenterology, Department of Medicine, Tampere University Hospital, Tampere (P.H.P.); and the Departments of Clinical Nutrition (T.A.K., R.M.K.J., M.I.J.U.) and Pathology and Forensic Medicine (V.-M.K.), University of Kuopio, Kuopio all in Finland.
Address reprint requests to Dr. Janatuinen at the Division of Gastroenterology, Department of Medicine, Kuopio University Hospital, P.O. 1777, SF-70211 Kuopio, Finland.
Oats in Celiac Disease
Branski D., Shine M., Janatuinen E. K., Julkunen R. J.K., Uusitupa M. J.U.
Extract |
Full Text
N Engl J Med 1996;
334:865-866, Mar 28, 1996.
Correspondence
This article has been cited by other articles:
STOLLER, J. K., TENG, K. A.
(2008). A young woman with fatigue. Cleveland Clinic Journal of Medicine
75: 215-219
[Full Text]
Haboubi, N Y, Taylor, S, Jones, S
(2006). Coeliac disease and oats: a systematic review.. Postgrad. Med. J.
82: 672-678
[Abstract][Full Text]
van Heel, D A, West, J
(2006). Recent advances in coeliac disease. Gut
55: 1037-1046
[Full Text]
Spaenij-Dekking, L., Kooy-Winkelaar, Y., Koning, F.
(2005). The Ethiopian cereal tef in celiac disease.. NEJM
353: 1748-1749
[Full Text]
Norris, J. M., Barriga, K., Hoffenberg, E. J., Taki, I., Miao, D., Haas, J. E., Emery, L. M., Sokol, R. J., Erlich, H. A., Eisenbarth, G. S., Rewers, M.
(2005). Risk of Celiac Disease Autoimmunity and Timing of Gluten Introduction in the Diet of Infants at Increased Risk of Disease. JAMA
293: 2343-2351
[Abstract][Full Text]
Thompson, T.
(2004). Gluten Contamination of Commercial Oat Products in the United States. NEJM
351: 2021-2022
[Full Text]
Spaenij-Dekking, E H A, Kooy-Winkelaar, E M C, Nieuwenhuizen, W F, Drijfhout, J W, Koning, F
(2004). A novel and sensitive method for the detection of T cell stimulatory epitopes of {alpha}/{beta}- and {gamma}-gliadin. Gut
53: 1267-1273
[Abstract][Full Text]
Hogberg, L, Laurin, P, Falth-Magnusson, K, Grant, C, Grodzinsky, E, Jansson, G, Ascher, H, Browaldh, L, Hammersjo, J-A, Lindberg, E, Myrdal, U, Stenhammar, L
(2004). Oats to children with newly diagnosed coeliac disease: a randomised double blind study. Gut
53: 649-654
[Abstract][Full Text]
Lundin, K E A, Nilsen, E M, Scott, H G, Loberg, E M, Gjoen, A, Bratlie, J, Skar, V, Mendez, E, Lovik, A, Kett, K
(2003). Oats induced villous atrophy in coeliac disease. Gut
52: 1649-1652
[Abstract][Full Text]
Kilmartin, C, Lynch, S, Abuzakouk, M, Wieser, H, Feighery, C
(2003). Avenin fails to induce a Th1 response in coeliac tissue following in vitro culture. Gut
52: 47-52
[Abstract][Full Text]
Dor, R, Shanahan, D J, Julkunen, R, Uusitupa, M
(2002). Oats and coeliac disease. Gut
51: 757-758
[Full Text]
Colli, A., Colucci, A., Conte, D., Gomollon, F., Tribole, E., Kupper, C., Pietzak, M., Spanier, B. W.M., Dietz, B., Mulder, C. J.J., Farrell, R. J., Kelly, C. P.
(2002). Celiac Sprue. NEJM
347: 446-448
[Full Text]
Collin, P., Kaukinen, K., Valimaki, M., Salmi, J.
(2002). Endocrinological Disorders and Celiac Disease. Endocr. Rev.
23: 464-483
[Abstract][Full Text]
Schwarzenberg, S. J., Brunzell, C.
(2002). Type 1 Diabetes and Celiac Disease: Overview and Medical Nutrition Therapy. Diabetes Spectr.
15: 197-201
[Full Text]
Vader, L. W., de Ru, A., van der Wal, Y., Kooy, Y. M.C., Benckhuijsen, W., Mearin, M. L., Drijfhout, J. W., van Veelen, P., Koning, F.
(2002). Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease. JEM
195: 643-649
[Abstract][Full Text]
Janatuinen, E K, Kemppainen, T A, Julkunen, R J K, Kosma, V-M, Maki, M, Heikkinen, M, Uusitupa, M I J
(2002). No harm from five year ingestion of oats in coeliac disease. Gut
50: 332-335
[Abstract][Full Text]
Farrell, R. J., Kelly, C. P.
(2002). Celiac Sprue. NEJM
346: 180-188
[Full Text]
Picarelli, A., Di Tola, M., Sabbatella, L., Gabrielli, F., Di Cello, T., Anania, M. C., Mastracchio, A., Silano, M., De Vincenzi, M.
(2001). Immunologic evidence of no harmful effect of oats in celiac disease. Am. J. Clin. Nutr.
74: 137-140
[Abstract][Full Text]
Janatuinen, E K, Kemppainen, T A, Pikkarainen, P H, Holm, K H, Kosma, V-M, Uusitupa, M I J, Maki, M, Julkunen, R J K
(2000). Lack of cellular and humoral immunological responses to oats in adults with coeliac disease. Gut
46: 327-331
[Abstract][Full Text]
Murray, J. A
(1999). The widening spectrum of celiac disease. Am. J. Clin. Nutr.
69: 354-365
[Abstract][Full Text]
Hardman, C., Fry, L., Tatham, A., Thomas, H. J.W.
(1999). Absence of Toxicity of Avenin in Patients with Dermatitis Herpetiformis. NEJM
340: 321-321
[Full Text]
Reunala, T, Collin, P, Holm, K, Pikkarainen, P, Miettinen, A, Vuolteenaho, N, Maki, M
(1998). Tolerance to oats in dermatitis herpetiformis. Gut
43: 490-493
[Abstract][Full Text]
FEIGHERY, C F
(1998). Coeliac disease: how much of what is toxic to whom?. Gut
43: 164-165
[Full Text]
Ellis, H J, Rosen-Bronson, S, O'Reilly, N, Ciclitira, P J
(1998). Measurement of gluten using a monoclonal antibody to a coeliac toxic peptide of A gliadin. Gut
43: 190-195
[Abstract][Full Text]
Parnell, N., Ellis, H. J., Ciclitira, P., Hardman, C. M., Fry, L.
(1998). Absence of Toxicity of Oats in Patients with Dermatitis Herpetiformis. NEJM
338: 1470-1471
[Full Text]
Hardman, C. M., Garioch, J. J., Leonard, J. N., Thomas, H. J.W., Walker, M. M., Lortan, J. E., Lister, A., Fry, L.
(1997). Absence of Toxicity of Oats in Patients with Dermatitis Herpetiformis. NEJM
337: 1884-1887
[Abstract][Full Text]
Schmitz, J.
(1997). Lack of oats toxicity in coeliac disease. BMJ
314: 159-159
[Full Text]
Srinivasan, U., Leonard, N., Jones, E., Kasarda, D. D, Weir, D. G, O'Farrelly, C., Feighery, C.
(1996). Absence of oats toxicity in adult coeliac disease. BMJ
313: 1300-1301
[Full Text]
Branski, D., Shine, M., Janatuinen, E. K., Julkunen, R. J.K., Uusitupa, M. J.U.
(1996). Oats in Celiac Disease. NEJM
334: 865-866
[Full Text]
(1995). OATS FOR PATIENTS WITH CELIAC DISEASE?. JWatch General
1995: 8-8
[Full Text]
Kumar, P. J., Farthing, M. G.J.
(1995). Oats and Celiac Disease. NEJM
333: 1075-1076
[Full Text]